| Steven Timothy Tvedte, MD | |
|
5409 Mount Normandale Curv, Bloomington, MN 55437-1019 | |
| (952) 921-0450 | |
| (952) 835-0999 |
| Full Name | Steven Timothy Tvedte |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 5409 Mount Normandale Curv, Bloomington, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184691362 | NPI | - | NPPES |
| 23936 | Other | MN | MN MEDICAL LICENSE |
| 20212 | Other | IA | IOWA MEDICAL LICENSE |
| 351783700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 23936 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steven Timothy Tvedte, MD Po Box 39478, Edina, MN 55439-0478 Ph: (952) 921-0450 | Steven Timothy Tvedte, MD 5409 Mount Normandale Curv, Bloomington, MN 55437-1019 Ph: (952) 921-0450 |
News Archive
Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated, beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.
NextBio today announced the latest evolution of its innovative life science research platform, adding new capabilities for the integration and mining of high-throughput array and next-generation sequencing data. The new NextBio Sequence-Centric module enables researchers to effectively explore and utilize massive amounts of public and internally generated sequencing data, while allowing organizations to create corporate-wide genomic data platforms to serve the needs of their global research teams.
FirstCare Health Plans announced today that it has earned three-year Accreditation status from the National Committee for Quality Assurance (NCQA).
New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
› Verified 7 days ago
Rebecca Lynn Meyer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Dr. Holly Lynn Schrupp Berg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Andrew H Bauer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Laura Kuhlman, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Elisabeth Marycke Vreede Greenberg, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Leonardo A Saavedra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Dr. Ferris Yeh, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 |